MedTrace Logo

Evaluation of the Effect of TMS on Primary Dysmenorrhea

NCT04168489 · Status: UNKNOWN · Phase: NA · Type: INTERVENTIONAL · Enrollment: 80

Last updated 2023-03-13

No results posted yet for this study

Summary

Based on the pain threshold and visual simulation score, primary dysmenorrhea patients will be divided into treatment effective group or non-effective group.According to the functional magnetic resonance imaging, the investigators investigate whether there is characteristic or secondary brain features before and after rTMS intervention.

Conditions

  • Primary Dysmenorrhea

Interventions

DEVICE

active rTMS

(rTMS) is received preliminary approval because of its noninvasive and safe analgesic effect.

DEVICE

sham rTMS

The sham rTMS is inactive and similar to placebo effect.

Sponsors & Collaborators

  • First Affiliated Hospital Xi'an Jiaotong University

    lead OTHER

Principal Investigators

  • wanghuan Dun, M.D. · The First Affiliated Hospital of Xi 'an Jiaotong University

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
SINGLE
Model
PARALLEL

Eligibility

Min Age
18 Years
Max Age
30 Years
Sex
FEMALE
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2022-07-20
Primary Completion
2023-12-30
Completion
2024-07-30

Countries

  • China

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT04168489 on ClinicalTrials.gov